Tuesday, September 17, 2019
Major mental illness is perhaps the most disabling medical problem in the world and the global health community has responded to this crisis with increasing technology. While these technologies may truly change the problem, the side effect may be that these same technologies change who we are as humans. Nolan Williams, M.D., assistant professor within the departments of psychiatry and behavioral sciences and the director of the Stanford Brain Stimulation Lab, will explore how novel neuro-technologies challenge our conception of who we are and how they may have a role in human evolution.
Nolan Williams, M.D., is an assistant professor within the departments of psychiatry and behavioral sciences and the director of the Stanford Brain Stimulation Lab at Stanford University.
Williams has a broad background in neuropsychiatry, completing residencies in both neurology and psychiatry. In addition, he has specific training and clinical expertise in the development of brain stimulation methodologies. Themes of his work include (a) examining the use of spaced learning theory in the application of neurostimulation techniques, (b) development and mechanistic understanding of rapid-acting antidepressants, and (c) identifying objective biomarkers that predict neuromodulation responses in treatment-resistant neuropsychiatric conditions.
He has published papers in many journals including Brain, American Journal of Psychiatry, and the Proceedings of the National Academy of Science. He has also contributed to two reviews related to novel therapeutics for neuropsychiatric conditions that have been published in the Journal of Clinical Investigation and Current Opinion in Neurobiology.
Results from his studies have gained widespread attention in journals such as Science and New England Journal of Medicine Journal Watch as well as in the popular press and have been featured in various news sources including Time, Smithsonian, and Newsweek.
Williams received an NIH R-series grant within two years of completing his residencies as well as two NARSAD Young Investigator Awards in 2016 and 2018 along with the 2019 Gerald R. Klerman Award. He started the Stanford Brain Stimulation Lab in 2015. He has received several merit-based travel awards to attend and present at the annual meetings for American College of Neuropharmacology, Society of Biological Psychiatry, the American Academy of Neurology and the American Neuropsychiatric Association.